'Cardio-COVID': Amal Mattu on COVID-19 and Matters of the Heart
This site is intended for healthcare professionals

COMMENTARY

'Cardio-COVID': Amal Mattu on COVID-19 and Matters of the Heart

Amal Mattu, MD

Disclosures

May 08, 2020

9

COVID-19, the disease caused by the novel coronavirus SARS-CoV-2, has produced morbidity and death in staggering numbers. At the time of this writing, COVID-19 is responsible for more than 210,000 deaths worldwide, including more than 56,000 deaths in the United States alone. By the time you read this, these numbers will have risen significantly.

The primary manifestation of COVID-19 is pulmonary in nature: fever with cough, dyspnea, and pneumonia. Now, anecdotal reports are suggesting that the virus also attacks the heart.

COVID-19: Is It Just the Lungs?

We've known that COVID-19 has profound pulmonary manifestations and can produce respiratory failure and acute respiratory distress syndrome. In recent months, however, we started hearing anecdotal reports from physicians in China and Italy about many of their patients who were not dying from pulmonary problems or hypoxemia. In fact, some would begin to show improvement from a pulmonary standpoint, but then, at around day 7 to 10 of symptoms, their condition would rapidly deteriorate because of deteriorating cardiac function.

We also heard reports that many of the critically ill patients never demonstrated radiographic signs of pneumonia, or that the radiographic findings did not correlate with the severity of the illness. Ruan and colleagues

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....